FDA 483 - Jeanne-Elyse G. Cedeno, M.D. - August 02, 2023

An FDA inspection of Jeanne-Elyse G. Cedeno, M.D. in Pembroke Pines, FL, revealed significant deviations in the conduct of a clinical study. The firm failed to adhere to the investigational plan, improperly reported adverse events, and maintained inaccurate case histories. These findings indicate a serious lack of compliance with clinical trial protocols and good clinical practices.